Recent Advances in the Treatment of Non-small Cell Lung Cancer with Brigatinib by Jia YU, Shengxiang REN

Get full text

Updates to the 2024 CSCO advanced non-small cell lung cancer guidelines by Jiale Wang, Tianyu Qiu, Shengxiang Ren

Get full text

Biomarkers and ImmuneScores in lung cancer: predictive insights for immunotherapy and combination treatment strategies by Xiaoyu Yang, Bin Luo, Jianhui Tian, Yanhong Wang, Xinyi Lu, Jian Ni, Yun Yang, Lei Jiang, Shengxiang Ren

Get full text

IFITM3 enhances immunosensitivity via MHC-I regulation and is associated with the efficacy of anti-PD-1/-L1 therapy in SCLC by Yanan Cui, Tianyu Qiu, Jiale Wang, Xinyu Liu, Libo Luo, Jizhong Yin, Xinxin Zhi, Wanying Wang, Gaohua Feng, Chunyan Wu, Zhikai Zhao, Hua Zhang, Fei Li, Fengying Wu, Shengxiang Ren

Get full text

Camrelizumab, an Anti‐PD‐1 Monoclonal Antibody, Plus Carboplatin and Nab‐Paclitaxel as First‐Line Setting for Extensive‐Stage Small‐Cell Lung Cancer: A Phase 2 Trial and Biomarker... by Jia Yu, Deyu Cai, Sha Zhao, Lei Wang, Xinlong Zheng, Anwen Xiong, Qi Wang, Bin Chen, Menghang Yang, Wei Li, Yan Wang, Jiajia Yuan, Changhong Zhao, Wei Shi, Caicun Zhou, Luonan Chen, Tao Jiang, Xiaohui Chen, Shengxiang Ren

Get full text

Indoleamine 2,3-dioxygenase-1 expression in non-small-cell lung cancer: analyses of prevalence, clinical correlations and prognostic impact in 2 large patient cohorts by Francesco Agustoni, Francesco Agustoni, Hui Yu, Kim Ellison, Derek Smith, Paul Mitchell, Gareth Rivalland, Rafal Dziadziuszko, Dexiang Gao, Shengxiang Ren, Christopher J. Rivard, Inigo San Millan, Inigo San Millan, Salvatore Corallo, Salvatore Corallo, Paolo Pedrazzoli, Paolo Pedrazzoli, Fred R. Hirsch

Get full text